Thyrocare Technologies (BOM:539871) Dividend Payout Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539871 Thyrocare Technologies Ltd BOM:539871
87 GF Score
Price ₹555.90
GF Value ₹431.41
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Thyrocare Technologies Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Thyrocare Technologies's Dividend Payout Ratio for the months ended in Jun. 2026 was .

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Thyrocare Technologies Ltd is 1.44, which seems too high.

The historical rank and industry rank for Thyrocare Technologies's Dividend Payout Ratio or its related term are showing as below:

BOM:539871' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33   Med: 0.79   Max: 1.59
Current: 1.44

During the past 13 years, the highest Dividend Payout Ratio of Thyrocare Technologies was 1.59. The lowest was 0.33. And the median was 0.79.

BOM:539871's Dividend Payout Ratio is ranked worse than
88.89% of 54 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.54 vs BOM:539871: 1.44

As of today (2026-09-21), the Dividend Yield % of Thyrocare Technologies is 1.68%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Thyrocare Technologies was 5.05%. The lowest was 0.34%. And the median was 1.89%.

Thyrocare Technologies's Dividends per Share for the months ended in Jun. 2026 was ₹.

During the past 12 months, Thyrocare Technologies's average Dividends Per Share Growth Rate was 172.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 23.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 18.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Thyrocare Technologies was 49.40% per year. The lowest was -15.70% per year. And the median was 21.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Thyrocare Technologies (BOM:539871) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Thyrocare Technologies Dividend Payout Ratio Related Terms

Thyrocare Technologies Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Thyrocare Technologies's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thyrocare Technologies Dividend Payout Ratio Chart

Thyrocare Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 1.48 1.35 3.66 0.89

Thyrocare Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.77 0.00 2.37 -

BOM:539871 vs TMO, DHR, NTRA: Dividend Payout Ratio Comparison

For the Diagnostics & Research subindustry, Thyrocare Technologies's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thyrocare Technologies Dividend Payout Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Dividend Payout Ratio falls into.


BOM:539871
87GF Score
Thyrocare Technologies Ltd BOM:539871
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thyrocare Technologies Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Thyrocare Technologies's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=9.333331/ 10.483515309261
=0.89

Thyrocare Technologies's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=/ 3.2199999999999
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Thyrocare Technologies (BOM:539871) Overvalued in 2026?

Based on GuruFocus' analysis, Thyrocare Technologies stock appears to be overvalued. The current stock price of ₹555.90 is trading 28.9% above its estimated GF Value™ of ₹431.41. GuruFocus considers Thyrocare Technologies to be Modestly Overvalued.

Key valuation signals for BOM:539871:

  • Dividend Payout Ratio:
  • GF Value™: ₹431.41 vs. price of ₹555.90 (28.9% above fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the BOM:539871 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thyrocare Technologies Business Description

Other Exchanges THYROCARE:India
Address D-37/3, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others: Sale of testing equipment and consumables. The Diagnostic Testing Services segment provides Diagnostic and testing services, selling of consumables used for the collection and promotion of the pathology segment. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates Diagnostic and imaging services, selling of radio-pharmaceuticals, and selling of consumables for reporting. The Other business segment is engaged in the selling of glucometers and glucostrips under the brand name Sugarscan. The company earns the vast majority of its revenue in India.
87GF Score

Get the complete analysis for BOM:539871

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹555.90
Price
₹431.41
GF Value